CN100411633C - Medicine composition for treating psoriasis - Google Patents
Medicine composition for treating psoriasis Download PDFInfo
- Publication number
- CN100411633C CN100411633C CNB021552398A CN02155239A CN100411633C CN 100411633 C CN100411633 C CN 100411633C CN B021552398 A CNB021552398 A CN B021552398A CN 02155239 A CN02155239 A CN 02155239A CN 100411633 C CN100411633 C CN 100411633C
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight
- calculus bovis
- radix
- calculus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a drug composition for treating psoriasis, which is prepared from the crude drugs of tripterygium wilfordii, black-tail snake, snow-in-June, tendrilleaf fritillary bulb, pleione pseudobulb, panax pseudo-ginseng, dyer woad leaf, oldenlandia, honeycomb of paper wasps, astragalus root, long-noded pit viper and bezoar the present invention has the advantages of obvious effect, small side effect and convenient administration for the treating psoriasis.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to the psoriatic pharmaceutical composition of a kind of treatment.
Background technology
Psoriasis is commonly called as psoriasis, is a kind of chronic, and outbreak is the intractable of characteristics, intractable dermatosis with the epidermis cell hyper-proliferative repeatedly, and the chronic dermatosis that easily recurs, and the lighter influences its outer table image, and weight person is threat to life health then.Bringing very for people's work, life and spirit seriously influences.At present, the research of its cause of disease is not still had final conclusion, but certainly not the superficial part mycete causes, and relevant with body's immunity, inherited genetic factors, Nervous and Mental Factors etc.At present, treating psoriatic method has multiplely, and the patient who has adopts the cyclosporin of import to treat, but the side effect of this medicine is very big, can cause hepar damnification even hepatic necrosis.Traditional tcm therapy is controlled psoriasis mostly with heat clearing away, removing heat from blood, the method for invigorating blood circulation, and curative effect is slow, and cure rate is low.
Technology contents
The object of the present invention is to provide a kind of to the treatment psoriasis have instant effect, side effect is little, the pharmaceutical composition of taking convenience.
The present invention is achieved through the following technical solutions: choose crude drug
Radix Tripterygii Wilfordii 150-450 weight portion Zaocys 100-300 weight portion
Serissa foetida 100-300 weight portion Bulbus Fritillariae Cirrhosae 100-300 weight portion
Pseudobulbus Cremastrae seu Pleiones 100-300 weight portion Radix Notoginseng 100-300 weight portion
Folium Isatidis 100-300 weight portion Herba Hedyotidis Diffusae 100-300 weight portion
Nidus Vespae 100-300 weight portion Radix Astragali 100-300 weight portion
Agkistrodon 20-40 weight portion Calculus Bovis 10-30 weight portion
Optimum ratio of the present invention is: choose crude drug
Radix Tripterygii Wilfordii 300 weight portion Zaocyss 200 weight portion Serissa foetida 200 weight portions
Bulbus Fritillariae Cirrhosae 200 weight portion Pseudobulbus Cremastrae seu Pleiones 200 weight portion Radix Notoginsengs 200 weight portions
Folium Isatidis 200 weight portion Herba Hedyotidis Diffusaes 200 weight portion Nidus Vespaes 200 weight portions
The Radix Astragali 200 weight portion Agkistrodons 30 weight portion Calculus Boviss 20 weight portions
Except that Calculus Bovis, the oven dry powder becomes fine powder to cross 120 mesh sieves and Calculus Bovis to mix thoroughly and get final product with the above-mentioned raw materials medicine.Each 2-6 gram, every day 1-2 time, boiled water is taken after mixing it with water after meal sooner or later.
The present invention treats psoriasis 606 examples (comprising homeliness type, abscess type, arthritis type and erythrodermic) totally 606 examples, obtains better effects.
The psoriatic of my section's outpatient service in January nineteen ninety, except that pregnant and lying-in women, child below 12 years old and light disease patient, all the other all adopt the present invention to treat, mostly be invalid and take pharmaceutical composition of the present invention in this group case history with Drug therapys such as Ethylenediamine Tetraacetylimine, amine Copeptin, bimolane, corticosteroid hormones, wherein male 318 examples, women 288 examples, age 13-68 year, stadium is the shortest 20 days, and is the longest 35 years.
This organizes 606 examples, cures 138 examples, accounts for 22.77%, and produce effects 428 examples account for 70.62%, and effective 38 examples account for 6.27%, and total effective rate is 99.6%, cures about 60 days of average time, and is the shortest 20 days, the longest 240 days.Treating various psoriasises with the present invention has tangible short-term effect, and total obvious effective rate reaches 93.4%, and total effective rate reaches 99.6%, and average 5 days take effect, reach more than the produce effects about 20 days.It is dark by red commentaries on classics to show as skin lesion, and squama reduces, and pruritus alleviates.
Embodiment
Choose crude drug:
Radix Tripterygii Wilfordii 300 gram Zaocyss 200 gram Serissa foetida 200 grams
Bulbus Fritillariae Cirrhosae 200 Keshan arrowheads 200 gram Radix Notoginsengs 200 grams
Folium Isatidis 200 gram Herba Hedyotidis Diffusaes 200 gram Nidus Vespaes 200 grams
The Radix Astragali 200 gram Agkistrodons 30 gram Calculus Boviss 20 grams
Except that Calculus Bovis, the oven dry powder becomes fine powder to cross 120 mesh sieves and Calculus Bovis to mix thoroughly and get final product with the above-mentioned raw materials medicine.Each 2-6 gram, every day 1-2 time, boiled water is taken after mixing it with water after meal sooner or later.
Claims (2)
1. treat psoriatic pharmaceutical composition for one kind, it is characterized in that said composition is to be made by following crude drug:
Radix Tripterygii Wilfordii 150-450 weight portion Zaocys 100-300 weight portion
Serissa foetida 100-300 weight portion Bulbus Fritillariae Cirrhosae 100-300 weight portion
Pseudobulbus Cremastrae seu Pleiones 100-300 weight portion Radix Notoginseng 100-300 weight portion
Folium Isatidis 100-300 weight portion Herba Hedyotidis Diffusae 100-300 weight portion
Nidus Vespae 100-300 weight portion Radix Astragali 100-300 weight portion
Agkistrodon 20-40 weight portion Calculus Bovis 10-30 weight portion,
Except that Calculus Bovis, the oven dry powder becomes fine powder to cross 120 mesh sieves and Calculus Bovis to mix thoroughly and get final product with the above-mentioned raw materials medicine.
2. pharmaceutical composition according to claim 1 is characterized in that said composition is to be made by following crude drug:
Radix Tripterygii Wilfordii 300 weight portion Zaocyss 200 weight portion Serissa foetida 200 weight portions
Bulbus Fritillariae Cirrhosae 200 weight portion Pseudobulbus Cremastrae seu Pleiones 200 weight portion Radix Notoginsengs 200 weight portions
Folium Isatidis 200 weight portion Herba Hedyotidis Diffusaes 200 weight portion Nidus Vespaes 200 weight portions
The Radix Astragali 200 weight portion Agkistrodons 30 weight portion Calculus Boviss 20 weight portions,
Except that Calculus Bovis, the oven dry powder becomes fine powder to cross 120 mesh sieves and Calculus Bovis to mix thoroughly and get final product with the above-mentioned raw materials medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021552398A CN100411633C (en) | 2002-12-10 | 2002-12-10 | Medicine composition for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021552398A CN100411633C (en) | 2002-12-10 | 2002-12-10 | Medicine composition for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1506101A CN1506101A (en) | 2004-06-23 |
| CN100411633C true CN100411633C (en) | 2008-08-20 |
Family
ID=34235813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021552398A Expired - Fee Related CN100411633C (en) | 2002-12-10 | 2002-12-10 | Medicine composition for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100411633C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101843766B (en) * | 2009-10-28 | 2011-08-31 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating psoriasis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300617A (en) * | 1999-12-23 | 2001-06-27 | 程家尧 | Composite Chinese medicine for regulating functions of human body |
| CN1406621A (en) * | 2001-09-07 | 2003-04-02 | 魏清明 | Medicines for treating psoriasis |
-
2002
- 2002-12-10 CN CNB021552398A patent/CN100411633C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1300617A (en) * | 1999-12-23 | 2001-06-27 | 程家尧 | Composite Chinese medicine for regulating functions of human body |
| CN1406621A (en) * | 2001-09-07 | 2003-04-02 | 魏清明 | Medicines for treating psoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1506101A (en) | 2004-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN101130023A (en) | Powder of codonopsis pilosula for warming stomach | |
| CN1332702C (en) | Medicine for treating psoriasis | |
| CN104069162B (en) | A kind of Chinese medicine for treating urarthritis and various bone joint pains | |
| CN105435125B (en) | A kind of Chinese herb medicine being beneficial to tumor in upper digestive tract postoperative rehabilitation | |
| CN100411633C (en) | Medicine composition for treating psoriasis | |
| CN106668631A (en) | Chinese herbal medicine for treating rhinitis | |
| CN1657067A (en) | Chinese medicine for treating psoriasis | |
| CN1103598C (en) | Chinese medicine for treating diabetes and preparation method therefor | |
| CN100334972C (en) | Body building health preparation and its producing method | |
| CN103495070B (en) | Navel-applied agent for treating bowel dysfunction after abdominal surgery | |
| CN103861067A (en) | Chinese medicine mixture for treating nasosinusitis | |
| CN102861292A (en) | Medicament for treating esophageal cancer and preparation method thereof | |
| CN101361855B (en) | Medicine for reducing and stabilizing blood-pressure | |
| CN100490873C (en) | Medicinal composition for treating high fever and preparation method thereof | |
| CN1238195A (en) | Chinese-medicinal capsule for treating different psychoses -'Kaiqiao Shushen' capsule | |
| CN1177597C (en) | Nose drops for rhinitis | |
| CN1377659A (en) | Rash-eliminating and psoriasis-treating medicine liquid | |
| CN105106468A (en) | Antineoplastic traditional Chinese medicine composition for medical oncology | |
| CN1413661A (en) | Chinese medicine capsule and external used medicine for treating skin carcinoma and its preparation method | |
| CN105381184A (en) | Traditional Chinese medicine pills capable of improving immunity of human body | |
| CN1363360A (en) | Bidirectional immunoregulating pill | |
| CN104258345A (en) | Heat-clearing, lung-moistening, phlegm-resolving and sound-improving traditional Chinese medicine | |
| CN103041178B (en) | Nursing paste capable of relieving low intracranial pressure after operation | |
| CN103285163A (en) | Formula of traditional Chinese medicine for treating diabetes with other complications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 Termination date: 20111210 |